ArticleThe Lancet regional health. Southeast Asia2026
Burden of subclinical coronary atherosclerosis among asymptomatic adults: the REACH-Rural India Study.
Article in The Lancet regional health. Southeast Asia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
21 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Coronary artery calcification (CAC) serves as a robust marker of subclinical atherosclerosis and an independent predictor of cardiovascular disease (CVD). Despite its clinical significance, population-based evidence on CAC prevalence and its determinants in rural India remains limited. This study aimed to estimate the prevalence of CAC and evaluate its association with cardiometabolic risk factors among adults aged 35-65 years in a rural Indian population. Methods: A total of 3006 individuals aged 35-65 years were selected and invited to participate in the REACH (Risk Evaluation of Subclinical Coronary Health)-Rural India Study. From 2022 to 2024, the study enrolled asymptomatic adults with no history of cardiovascular events from rural communities in the Coimbatore and Tirupur districts of Tamil Nadu, India. Data collection included sociodemographic and clinical profiling, laboratory testing, and carotid intima-media thickness (cIMT). CAC was quantified using the Agatston scoring method from dual-source CT scans. Findings: In total 2961 participants included in the final analysis (mean age 49.8 ± 8.3 years; 52.8% women), the overall prevalence of coronary artery calcification (CAC) was 25.6%. Prevalence was significantly higher in men (33.5%) than in women (18.5%) (p < 0.001). The prevalence of severe CAC (Agatston score >400) was threefold higher in men and most common in those aged 56-65 years. However, no detectable CAC was observed among women aged 35-45 years. The distribution of CAC scores was as follows: 7.0% had minimal CAC (1-10), 11.4% mild (11-100), 5.2% moderate (101-400), and 1.9% severe (>400). Multivariable logistic regression showed that diabetes, hypertension, overweight/obesity, and abnormal CIMT were independently associated with CAC. Among men, current smoking was also significantly associated (OR = 1.51; 95% CI: 1.18-1.93). In total, 83.5% of individuals with CAC had one or more cardiovascular risk factors. No significant associations were observed between CAC and elevated creatinine, reduced eGFR and peripheral artery disease (PAD) after full adjustment. Interpretation: This study reveals a substantial burden of CAC in a rural Indian population, with prevalence patterns comparable to urban cohorts in Western countries. The findings underscore the need to incorporate CAC screening in individuals with metabolic risk factors, especially in underserved populations, to identify early subclinical atherosclerosis and reduce CVD risk. Funding: Indian Council of Medical Research (ICMR), (REF No. 5/4/1-9/2020-NCD-1).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.